Abstract:Background: Considering the adverse reactions and side effects of immunosuppressive and cytotoxic drugs for the treatment of Primary Nephrotic Syndrome (PNS) and the extensive exploration of Chinese herbal injections (CHIs), systematic evaluation of the efficacy of different CHIs in the treatment of PNS is a key imperative. In this study, we performed a network meta-analysis to investigate the efficacy of CHIs in the treatment of PNS.Methods: A systematic literature review including studies published from the establishment of each database to May 28, 2020, was conducted in PubMed, the Cochrane Library, Embase, Web of Science, the Chinese Biological Medicine Literature Service System (CBM), the China National Knowledge Infrastructure (CNKI) database, the Chinese Scientific Journal Database (VIP), and the Wanfang Database (WF).Two evaluators independently screened the literature, extracted data and the Cochrane Reviewer's Handbook 5.1 method was used to evaluate the quality of included studies. The differences in efficacy of different CHIs were compared and ranked using Stata 16.0 software. Surface under the cumulative ranking curve (SUCRA) probability values were applied to rank the examined treatments. Clustering analysis was performed to compare the effects of CHIs between two different outcomes.Results: A total of 41 eligible randomized controlled trials involving 2879 patients and nine CHIs were included. Nine CHIs were Xiangdan injection (XDI), Huangqi injection (HQI), Shenkang injection (SKI), Danshen injection (DSI), Yinxingdamo injection (YXI), Dengzhanhuasu injection (DZI), Danhong injection (DHI), Shuxuetong injection (SXI), Chuanxiongqin injection (CXI). The results of the network meta-analysis showed that: with Western medical (WM) treatment as a co-intervention, in terms of improving the total clinical effectiveness and serum albumin level, DHI was the most likely to be the best choice for treatment (SUCRA = 82.2%); YXI had the highest probability of being the best option in terms of reducing 24-h urinary protein excretion (SUCRA = 97.8%); in cholesterol-lowering comparisons, the SUCRA value allows for the most likely to be the best treatment is DZI (SUCRA = 84.5%). SXI was the most effective CHIs in terms of lowering serum triglycerides (SUCRA = 85.6%), whereas on the reducing fibrinogen side, the efficacy of CXI was significant (SUCRA = 67.6%). The result cluster analysis indicated that YXI and DHI were the best interventions with respect to total clinical effectiveness, 24-h urinary protein excretion and serum albumin.Conclusions: CHIs were found to be superior to WM alone in the treatment of PNS and may be beneficial for patients with PNS. WM+YXI and WM+DHI had the potential to be the best CHI with respect to the total clinical effectiveness, 24-h urinary protein excretion and serum albumin. However, more well-designed randomized controlled trials are still warranted.

Study of the Effect of Xingding Injection on Hemorheology in Patients with Primary Nephritic Syndrome

Effect of Xingnaojing Injection on nitric oxide, insulin-like growth factor-1 and macrophage inhibitory factor of hypertensive patients with intracerebral hemorrhage

Effect of Xingding Injection on Active Serum Oxygen Levels and Hemorheology of Diabetic Nephropathy Patients

Effect of Shuxuetong Injection on Hemorheology and Clotting index in the Treatment of Nephrotic Syndrome

Effect of Jiangzhi Shuxin Decoction for Chronic Stable Angina Pectoris:An Observation of 79 Cases

Effect of Yishenjuanshi traditional Chinese drug on refractory nephrotic syndrome

Clinical Effect of Sulfontanshinone ⅡA Sodium Injection Plus Prednisone in Primary Nephrotic Syndrome

Clinical Effect Analysis of Xueshuantong Lyophilized Powder for Injection on Hypercoagulation and Hyperlipidemia of the Patients with Nephrotic Syndrome

Effect of Xingding injection on thrombomodulin and von Willebrand factor in patients with diabetic nephropathy

Efficacy of Chinese Herbal Injections for the Treatment of Primary Nephrotic Syndrome: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

To Compare the Curative Effect of the Antiplatelet Therapy Between Puerarin Injection and Xueshuantong Injection Among Patients with Unstable Angina After Percutaneous Coronary Stent Implantation

Effects of Dengzhanhua Injection on Hemorrheology and Renal Function Inpatients with Chronic Renal Failure

Influence and clinical efficacy of Tripterygium glycosides combined with glucocorticoid on regulatory T cells of patients with nephritic syndrome

A Meta- analysis of Radix Astragali for Primary Nephrotic Syndrome in Adults

To explore the effect of Xingnaojing injection in treatment of ischemic cerebralvascular disease

Effect of TanshinoneⅡA Sulfonic Acid Natfium Injection on Angina Pectoris and Hemorrheology in Patients with Coronary Artery Disease

Experimental Study on NF-kB of Adriamycin-Induced Nephroitic Rats and Treatment with Shenkangling

The Control Study on Yinxingdamo Injection in the Treatment of Acute Facial Palsy

Clinical observation on effect of Xuebijing injection for treatment of patients with diabetic nephropathy

Xingnaojing Injection for Intracerebral Hemorrhage: A Systematic Review

The Change and Significance of CD4~+ CD25~+ T Regulatory Cell and T Lymphocyte Subpopulation in Children with Primary Nephritic Syndrome